Riboswitch-based antibacterial drug discovery using high-throughput screening methods.

Area of Science:

• Molecular Biology
• Genetics
• Microbiology

Background:

• Bacterial riboswitches are RNA domains in mRNA that bind metabolites to regulate gene expression.
• These RNA switches allow bacteria to sense physiological changes and control metabolic pathways.
• The discovery of riboswitches has rapidly expanded over the last decade, revealing their widespread use in bacteria.

Purpose of the Study:

• To review mechanisms of bacterial riboswitch gene expression control.
• To highlight riboswitches in human bacterial pathogens as potential antibacterial drug targets.
• To discuss high-throughput screening approaches for riboswitch-targeted drug development.

Main Methods:

• Literature review of bacterial riboswitches and their functions.
• Analysis of riboswitch classes found in human bacterial pathogens.
• Discussion of in silico, in vitro, and in vivo screening methods for drug discovery.

Main Results:

• 17 distinct classes of bacterial riboswitches identified in 36 human pathogens.
• Riboswitches regulate the synthesis of essential metabolites in bacteria.
• These riboswitches represent promising targets for novel antibacterial agents.

Conclusions:

• Bacterial riboswitches are crucial regulatory elements with therapeutic potential.
• Targeting riboswitches in pathogens offers a strategy to combat antibiotic resistance.
• High-throughput screening is vital for developing new antibiotics against bacterial riboswitches.